PROF. JILL P RUIZ MD NPI 1821207044

NPI Details

PROF. Jill P Ruiz, MD is a radiation oncology radiology in Denison, TX with 21 years of experience. The provider is a radiologist who deals with the therapeutic applications of radiant energy and its modifiers and the study and management of disease, especially malignant tumors. PROF. Jill P Ruiz, MD NPI is 1821207044. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: TEXAS A & M UNIVERSITY SYSTEM, HSC, COLLEGE OF MEDICINE
Graduation Year:2005

The provider's business location address is:

5125 TEXOMA MEDICAL CENTER DR STE 100
DENISON, TX
ZIP 75020-084
Phone: (903) 868-4700
Fax: (903) 892-4910

The NPI 1821207044 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Ct guidance for insertion of radiation therapy fields (HCPCS:77014)
• Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session (HCPCS:G6015)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Continuing radiation therapy consultation per week (HCPCS:77336)
• Radiation treatment management, 5 treatment sessions (HCPCS:77427)
• Calculation of radiation therapy dose (HCPCS:77300)
• Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev (HCPCS:G6013)
• Design and construction of complex radiation treatment device (HCPCS:77334)
• Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev (HCPCS:G6012)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection, etoposide, 10 mg (HCPCS:J9181)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Complex radiation therapy planning (HCPCS:77263)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• X-ray during radiation therapy (HCPCS:77417)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Cranial lesion surgery using radiation over multiple sessions (HCPCS:77373)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Design and construction of radiation treatment device for high precision radiation therapy (HCPCS:77338)
• High precision radiation therapy planning (HCPCS:77301)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved (HCPCS:77290)
• Obtaining data needed to develop the optimal radiation treatment, 1 treatment area (HCPCS:77280)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• High dose radiation therapy, 2-12 channels (HCPCS:77771)
• 3d radiation therapy planning (HCPCS:77295)
• Unclassified drugs (HCPCS:J3490)
• Blood creatinine level (HCPCS:82565)
• Ct scan of chest with contrast (HCPCS:71260)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Obtaining respiratory data needed to develop the optimal radiation treatment (HCPCS:77293)
• Design and construction of simple radiation treatment device (HCPCS:77332)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Management of cranial lesion surgery using radiation over multiple sessions (HCPCS:77435)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Complex radiation therapy planning for delivery of external radiation (HCPCS:77307)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Injection of drug or substance into vein (HCPCS:96374)
• Special medical radiation therapy consultation (HCPCS:77370)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Ct scan of soft tissue of neck with contrast (HCPCS:70491)
• Ct scan of chest without contrast (HCPCS:71250)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)

The enumeration date for this NPI number is 5/22/2007 and was last updated on 7/10/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.